Fostering young researchers worldwide
In 1983, the Boehringer Ingelheim Fonds was established as a public foundation. An independent, non-profit institution, its purpose is the exclusive and direct promotion of basic research in biomedicine. The Boehringer Ingelheim Fonds supports the most talented young researchers worldwide whose PhD or MD projects are aimed at experimentally elucidating basic phenomena of human life.
Only the best applicants are accepted after an extremely rigorous application process.
Twice a year, the Boehringer Ingelheim Fonds invites scientists of worldwide repute to its International Titisee Conferences. Since 1962, experts from all nations have been meeting in the Black Forest (southern Germany) to discuss the latest results and developments in different areas of the molecular life sciences. Click here to read more about Boehringer Ingelheim Fonds
-
Research & Development
-
Hanns Strobel
-
Otto Thomae
-
Georg Scheuing
-
BioXcellence
Boehringer Ingelheim BioXcellence™ is one of the world´s leading companies for contract development and manufacturing of biopharmaceuticals
-
BioXcellence
Boehringer Ingelheim BioXcellence™ provides the entire drug product manufacturing chain comprising filling, lyophilisation and visual inspection. Within our global manufacturing network, we can supply different dosage forms.
-
BioXcellence
The process development of biopharmaceuticals requires specific expertise in both up- and downstream, as well as in protein analytics. By outsourcing the process development of your biotechnology projects to Boehringer Ingelheim BioXcellence™, you gain access not only to a team of highly skilled and experienced staff, but also to the most innovative technologies.
-
Research Institute of Molecular Pathology